Si-Bone Inc (SIBN) - Total Liabilities

Latest as of March 2026: $63.78 Million USD

Based on the latest financial reports, Si-Bone Inc (SIBN) has total liabilities worth $63.78 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Si-Bone Inc - Total Liabilities Trend (2013–2025)

This chart illustrates how Si-Bone Inc's total liabilities have evolved over time, based on quarterly financial data. See Si-Bone Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

Si-Bone Inc Competitors by Total Liabilities

The table below lists competitors of Si-Bone Inc ranked by their total liabilities.

Company Country Total Liabilities
NanJing Sanchao Advanced Materials Co Ltd
SHE:300554
China CN¥222.39 Million
Sunrise Energy Metals Ltd
AU:SRL
Australia AU$1.37 Million
Capital Bancorp
NASDAQ:CBNK
USA $3.40 Billion
Djerriwarrh Investments Ltd
AU:DJW
Australia AU$75.50 Million
Jiangsu Phoenix Property Investment Co Ltd
SHG:600716
China CN¥1.87 Billion
Perusahaan Perkebunan London Sumatra Indonesia Tbk PT
JK:LSIP
Indonesia Rp1.77 Trillion
Nanjing Central Emporium Group Stocks Co Ltd
SHG:600280
China CN¥9.62 Billion
Bank Maspion Indonesia PT
JK:BMAS
Indonesia Rp18.62 Trillion

Liability Composition Analysis (2013–2025)

This chart breaks down Si-Bone Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Si-Bone Inc.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 9.99 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.36 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.26 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Si-Bone Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Si-Bone Inc (2013–2025)

The table below shows the annual total liabilities of Si-Bone Inc from 2013 to 2025.

Year Total Liabilities Change
2025-12-31 $61.02 Million -3.86%
2024-12-31 $63.47 Million +3.97%
2023-12-31 $61.05 Million +3.04%
2022-12-31 $59.25 Million +5.64%
2021-12-31 $56.09 Million +4.29%
2020-12-31 $53.78 Million -0.41%
2019-12-31 $54.00 Million +11.74%
2018-12-31 $48.33 Million -70.75%
2017-12-31 $165.21 Million +11.50%
2016-12-31 $148.17 Million +351.43%
2015-12-31 $32.82 Million +48.56%
2014-12-31 $22.09 Million +12.34%
2013-12-31 $19.67 Million --

About Si-Bone Inc

NASDAQ:SIBN USA Medical Devices
Market Cap
$681.80 Million
Market Cap Rank
#12312 Global
#3013 in USA
Share Price
$15.41
Change (1 day)
+1.92%
52-Week Range
$11.61 - $21.40
All Time High
$35.96
About

SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium … Read more